Estudo randomizado | Efeito da terapia de manutenção com capecitabina aliada ao melhor cuidado de suporte vs. melhor cuidado de suporte isoladamente na sobrevida livre de progressão entre pacientes com carcinoma nasofaríngeo metastático recém-diagnosticado que receberam quimioterapia de indução.

Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial – JAMA Oncology (link para o resumo – $ para o texto completo)

Comentário no Twitter

Randomized trial of efficacy and safety of capecitabine maintenance therapy in metastatic nasopharyngeal carcinoma demonstrates that capecitabine maintenance therapy improved survival & was associated with manageable toxicities. https://t.co/Ay2WZ7ZuCN pic.twitter.com/sZJ6qfzCOY

— JAMA Oncology (@JAMAOnc) February 17, 2022